Product Description
The global PIVC market was valued at $1.7 billion in 2025. This is expected to increase over the forecast period at a CAGR of 2.1% to reach $1.9 billion by 2032.
The full report suite on the global market for peripheral intravenous catheters (PIVCs) includes two segments: conventional and safety PIVCs. Safety PIVCs are designed to protect healthcare professionals and patients against needlestick injuries. The safety PIVC segment includes both blood control PIVCs (those devices that protect against blood splatter) and non-blood control PIVCs. In addition to these product-based categories, the market is also segmented by care setting, which includes acute care and alternate care.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Peripheral Intravenous Catheter Market Trends
PIVC dwell times continue to lengthen as clinically indicated removal becomes more widely adopted. Rather than replacing catheters on a fixed schedule, PIVCs are increasingly removed only when a complication occurs or therapy ends. This shift reduces unnecessary line replacements and lowers the number of PIVCs used per patient. As a result, unit volume growth in the PIVC market remains constrained, limiting overall market expansion despite the high prevalence of PIVC use across care settings.
Global Peripheral Intravenous Catheter Market Share Insights
- Becton Dickinson, in 2025, led the PIVC market, driving the conversion to safety and blood control PIVCs. Its offerings cover major segments and the company is the leader of the non-blood control safety segment, due mostly to sales of Insyte® Autoguard®. In the blood control segment, Becton Dickinson sells the Nexiva™ devices and the Insyte® Autoguard® BC.
- Braun’s Introcan Safety® IV catheters and Introcan Safety® 3 closed IV catheters compete in the safety PIVC market. These devices, resembling conventional PIVCs, gained popularity due to automatic and unbypassable safety features. Lower-priced PIVCs contributed to increased market share. Their Ster-ASSIST™ peripheral IV catheter insertion kit aligns with the trend toward ultrasound-guided PIVC insertion, even without major endorsements from organizations for ultrasound guidance.
- ICU Medical ranked third in the PIVC market, offering an array of conventional and safety products. Jelco® ProtectIV® competes with BD’s Insyte® Autoguard® in the safety sector. Its acquisition of Smiths Medical bolstered its position. OPTIVA®, made from Ocrilon® polyurethane, reduces phlebitis risk.
Global Peripheral Intravenous Catheter Market Segmentation Summary
- Conventional PIVC Market
- Safety PIVC Market – Further Segmented Into:
- Blood Control: Integrated and Non-Integrated.
- Non-Blood Control: Active and Passive.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
